Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
WATERTOWN, Mass., Jan. 28, 2016 -- A U.S. District Court of Massachusetts jury verdict has found Kaz USA, Inc. of Southborough, MA, a subsidiary of Helen of Troy, Ltd of Hamilton, Bermuda, and the supplier of the Vicks V977 Forehead Thermometer and the Braun FHT1000 Forehead Thermometer, to have infringed United States Patent Nos. 6,292,685 (‘685 patent) and 7,787,938 (‘938 patent) owned by Exergen Corporation. All 12 claims asserted, including three claims in the ‘685 patent and nine claims in the ‘938 patent, were found valid and infringed. The infringing Vicks and Braun forehead thermometers are made in China, designed and manufactured by Microlife Corporation of Taipei, Taiwan, and sold to retailers by Kaz USA.
After a two week trial and four hours of deliberation, the eight person federal jury entered a unanimous verdict for Exergen in all 65 questions placed before the jury regarding direct infringement, induced infringement, contributory infringement, patent validity, and damages owed to Exergen.
A recognized world leader in medical and industrial non-invasive temperature technologies, Exergen has been developing and patenting its non-invasive thermometer technology for three decades. The company’s Founder and President Francesco Pompei, Ph.D, also a Harvard research scientist, is the inventor of over 60 issued United States patents.
“I started Exergen in my basement to develop new heat sensing technology in 1980 and since then have developed non-invasive temperature sensors that are used in a multitude of applications, from home and professional medical thermometers to heat sensors used by NASA,” says Dr. Pompei. “We are pleased that the U.S. Patent System and the Federal Courts make it possible for small companies like Exergen to protect our breakthrough patented technology and years of work to gain market acceptance from infringement by much larger companies and those who wished to ‘step on Exergen’s throat,’ as trial testimony indicated.”
Exergen’s patented award-winning TemporalScanner™ temporal artery thermometers are manufactured in Watertown, MA from components and materials sourced worldwide. They are relied upon for fast, accurate, non-invasive temperatures in thousands of hospitals and clinics and millions of homes. With more than 50 published clinical studies attesting to accuracy for all ages and all areas of medical care, the Exergen TemporalScanner is the #1 thermometer in proven accuracy, and the #1 preference of pediatricians, nurses, and moms.
Contact: Melissa Rubin Rosica Public Relations [email protected] P: 201.843.5600 F: 201.843.5680 95 Route 17 South, Suite 202 Paramus, New Jersey 07652
